1. Department of Oncology, Faculty of Medicine and Health, Örebro University Hospital, Örebro, Sweden
2. Nordic Market Access AB, Stockholm, Sweden
3. Parexel International, Stockholm, Sweden
4. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
5. Novartis Sverige AB, Kista, Sweden
6. Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology; Clinical Oncology, Faculty of Medicine, Uppsala University Hospital, Uppsala, Sweden